116 Street Community Newsletter — December 2022
Content at the intersection of entrepreneurship, venture capital, and our Columbia community.

IN THIS ISSUE: Read a feature story on portfolio company Genetesis; join a webinar on January 12, February 2, or 4; still time to diversify your portfolio; 2022 holiday gift guide; portfolio news; and more.
116 Street Portfolio Spotlight

Genetesis provides a commercially deployed, MRI-like machine called CardioFlux. It can rapidly diagnose the severity of chest pain symptoms without needing more intrusive, costly, and time-consuming testing. Read Feature Story »
UPCOMING WEBINARS
Top 10 Questions Prospective Investors Ask Us

Join one of our upcoming webinars with Managing Partner Ludwig Schulze for answers to the top 10 questions prospective investors ask. Ludwig will review the goal and structure of the fund, the value of our model, the benefits of diversifying into VC, and more. Click below to learn more and register:
Still Time to Diversify Your Portfolio

If you would like to diversify your portfolio in these times of public market volatility, please visit our fund portal to learn more and join us, or schedule a 1×1 call for specific investing questions.
116 Street Portfolio Companies in the News

We’re excited to present some of the innovative products and services from Alumni Ventures’ portfolio, including 116 Street portfolio company Endless West — a company redefining the art and science of great spirits. Learn More »
FOR CURRENT INVESTORS

Visit Your Club Portal
We invite existing investors to visit your Club portal for updates from Managing Partner Ludwig Schulze and our team, including webinars and events, Syndications, portfolio news, and more. Visit Club Portal »
What’s New at Alumni Ventures

Learn How Venture Capitalists Vet Deals
One of the cornerstones of making a successful venture investment is to conduct the right diligence, with consideration for stage, sector, and even the business model of the underlying opportunity. In this video, we discuss areas we evaluate before we invest. Watch Now »
Contact [email protected] for additional information. To see additional risk factors and investment considerations, visit av-funds.com/disclosures.